7378
N. Alharbi et al. / Tetrahedron 70 (2014) 7370e7379
adding amidine 14 (1.00 g, 4.25 mmol), BINAP (0.13 g, 0.21 mmol)
and PdCl2(MeCN)2 (0.06 g, 0.21 mmol). After purification, the yel-
low solid was recrystallised from a DCM:petroleum ether (1:1) to
yield the title compound as yellow needles (300 mg, 25%); mp
diglyme (0.5 ml), heating at 220 ꢀC for 10 min under argon and
initially adding aminoisoindoline 17 (100.0 mg, 0.40 mmol) and
phthalonitrile (51.0 mg, 0.40 mmol) in dry diglyme (1.0 ml) over 1 h.
Finally, a solution of phthalonitrile (51.0 mg, 0.40 mmol) and
DABCO (67.0 mg, 0.60 mmol) in dry diglyme (0.5 ml) was added
dropwise over 1 h. The purified product recrystallised from ace-
tone/EtOH (1:1) gave the title compound as green crystals with
167e168 ꢀC;; UVevis (DCM) lmax/nm (
3
) 367 (1.18ꢁ103), 290
(3.36ꢁ102); nmax/cmꢂ1 (ATR) 3600e3050 (br), 1589, 1416; 1H NMR
(500 MHz, CDCl3, 298 K):
d
(ppm) 7.79 (d, J¼7.5 Hz, 1H), 7.51e7.47
(m, 2H), 7.40 (t, J¼7.4 Hz, 1H), 7.30 (d, J¼2.0 Hz, 2H), 6.70 (s, 1H),
purple reflex (50 mg, 20%); mp >300 ꢀC; UVevis (THF) lmax/nm (
)
3
6.42 (t, J¼2.3 Hz, 1H), 3.87 (s, 6H); 13C NMR (125.7 MHz, CDCl3,
670 (7.35ꢁ103), 647 (4.41ꢁ103), 592 (1.03ꢁ102), 442 (1.03ꢁ102),
298 K):
d (ppm) 164.76, 160.91, 159.76, 154.32, 153.83, 152.80,
397 (2.50ꢁ102); nmax/cmꢂ1 (ATR) 2930, 1463, 1379; 1H NMR
138.20, 131.11, 129.80, 128.82, 127.64, 127.30, 120.05, 119.39, 108.49,
100.66, 55.61; MS (MALDI-TOF) m/z 281 [M]þ (100%); HRMS (ESI)
(C17H17N2O2) [MþH]þ: calcd: 281.1285; found: 281.1287.
(500 MHz, THF-d8, 298 K):
d
(ppm) 9.59 (d, J¼7.5 Hz, 2H), 9.53e9.50
(m, 4H), 8.23e8.15 (m, 4H), 7.92 (t, J¼7.1 Hz, 2H), 7.88e7.84 (m, 1H),
7.77e7.68 (m, 2H), 7.63e7.59 (m, 3H), 7.25 (d, J¼8.0 Hz, 2H), 3.98 (s,
3H); 13C NMR (125.7 MHz, THF-d8, 298 K):
d (ppm) 169.56, 161.75,
4.4.3. (Z/E)-1(1-Pyrenylmethylene)-1H-isoindol-3-amine
23. Synthesised following the general procedure described above
using a solution of 1-ethynylpyrene (500 mg, 2.2 mmol) and DBU
(0.7 mL) in dry DMF (10 ml) and adding amidine 14 (435 mg,
1.85 mmol), BINAP (69 mg, 0.11 mmol) and PdCl2(MeCN)2 (24 mg,
0.092 mmol). The crude product was purified by column chroma-
tography using DCM then DCM/MeOH (9:1 to 2:1) as solvent gra-
dient to afford the title compound a bright yellow solid, an
approximate 3:1 mixture of stereoisomers (455 mg, 72%); mp
156.84, 153.81, 152.87, 145.09, 143.05, 141.13, 141.00, 140.90, 140.20,
134.79, 134.51, 133.67, 132.79, 130.86, 130.09, 129.80, 128.24, 127.39,
126.63,125.81,125.69,123.86,123.76,123.64,123.58,122.46,118.90,
115.86, 108.56, 98.90, 56.04; MS (MALDI-TOF) m/z 642 [M]þ (100%);
HRMS (ESI) (C40H23MgN7O) [MþH]þ: calcd: 642.1887; found:
642.1885.
4.5.2. (20-(3,5-Dimethoxyphenyl)-tetrabenzo[b,g,q,l]-5,10,15-
triazaporphyrinato)magnesium 22. Synthesised following the gen-
eral procedure described above using a solution of phthalonitrile
(210 mg, 1.64 mmol) and MgBr2 (148 mg, 0.80 mmol) in dry
diglyme (0.5 ml), heating at 220 ꢀC for 10 min under argon and
initially adding aminoisoindoline 18 (150 mg, 0.54 mmol) and
phthalonitrile (69 mg, 0.54 mmol) in dry diglyme (1.0 ml) over 1 h.
Finally, a solution of phthalonitrile (69 mg, 0.54 mmol) and DABCO
(90 mg, 0.80 mmol) in dry diglyme (0.5 ml) was added dropwise
over 1 h. The purified product recrystallised from acetone/EtOH
(1:1) gave the title compound as green crystals with purple reflex
280e282 ꢀC;; UVevis (DCM) lmax/nm (
3
) 403 (7.64ꢁ103), 238
(1.62ꢁ104); nmax/cmꢂ1 (ATR) 3600e2900 (br), 1652, 1543, 1436; 1H
NMR (500 MHz, CDCl3, 298 K):
d (ppm) major isomer 8.97 (d,
J¼8.1 Hz, 1H), 8.45 (d, J¼9.2 Hz, 1H), 8.22e7.98 (m, 6H), 7.97 (t,
J¼7.6 Hz, 1H),; 7.93 (d, J¼7.6 Hz, 1H), 7.65 (s, 1H, H-a), 7.50 (br td,
J¼7.5, 1.1 Hz, 1H), 7.45 (br dt, J¼7.6, 0.9 Hz, 1H), 7.37 (br td, J¼7.4,
0.9 Hz, 1H), 5.4e4.2 (br s, 2H, NH2); minor isomer 8.23 (d, J¼9.1 Hz,
1H), 8.22e7.98 (m, 8H), 7.69 (s, 1H, H-a), 7.54 (d, J¼7.8 Hz, 1H), 7.22
(br td, J¼7.4, 1.1 Hz, 1H), 7.02 (br td, J¼7.6, 1.0 Hz, 1H), 6.96 (br dt,
J¼7.9 Hz, 0.9, 1H), 5.4e4.2 (br s, 2H, NH2); MS (MALDI-TOF) m/z 344
[M]þ (100%); HRMS (ESI) (C25H17N2) [MþH]þ: calcd: 345.1386;
found: 345.1386.
(30 mg, 8%); mp >300 ꢀC; UVevis (THF) lmax/nm
( ) 670
3
(6.45ꢁ103), 647 (4.23ꢁ103), 594 (1.21ꢁ102), 443 (1.41ꢁ102), 395
(2.82ꢁ103); nmax/cmꢂ1 (ATR) 2934, 1470; 1H NMR (500 MHz, THF-
d8, 298 K):
d
(ppm) 9.59 (d, J¼7.5 Hz, 2H), 9.53e9.50 (m, 4H),
4.5. General synthetic procedure for the synthesis of meso-
aryl TBTAPs via aminoisoindoline intermediates
8.20e8.15 (m, 4H), 7.93 (t, J¼7.6 Hz, 2H), 7.65 (t, J¼8.0 Hz, 2H), 7.45
(d, J¼8.0 Hz, 2H), 7.34 (d, J¼2.3 Hz, 2H), 7.18 (t, J¼2.3 Hz,1H), 3.95 (s,
6H); 13C NMR (125.7 MHz, THF-d8, 298 K):
d (ppm) 162.77, 156.73,
A suspension of phthalonitrile (ca. 150 mg, 3 equiv) and MgBr2
(1.5 equiv) in dry diglyme (0.5 mL) was heated at 220 ꢀC for 10 min
under an argon atmosphere, in a preheated mantle. A solution of
aminoisoindoline (1 equiv) and phthalonitrile (1 equiv) in dry
diglyme (1 ml) was added dropwise over 1 h using a syringe pump.
After finishing the first addition, the reaction mixture was left to
reflux at 220 ꢀC for 30 min. Finally, a solution of phthalonitrile
(1 equiv) and DABCO (1.5 equiv) in dry diglyme (0.5 ml) was added
dropwise over 1 h. The reaction mixture was then refluxed at
220 ꢀC under argon for further 30 min. A stream of argon was
passed through the reaction vessel in order to remove the solvent.
The reaction mixture was cooled to room temperature and a mix-
ture of DCM/MeOH (50 ml, 1:1) was added and the mixture soni-
cated. After removal the solvent under reduced pressure, the
resulting material was purified by two consecutive flash chroma-
tographies. Firstly, the crude was loaded on a silica-gel column and
eluted with DCM/Et3N/THF (10:1:4) in order to remove the yellow-
brown impurities and obtain a green fraction. The green fraction
was then subjected to a second column chromatography using PE/
THF/MeOH (10:3:1) as eluent to obtain the pure green product.
Alternatively, analytically pure material could be obtained by size-
exclusion chromatography over Bio-beads SX-3 using THF eluent.
153.72, 152.83, 145.37, 142.92, 142.14, 141.16, 140.93, 140.21, 130.07,
129.78, 128.35, 127.41, 126.68, 125.97, 123.85, 123.65, 123.54, 111.75,
102.25, 56.14; MS (MALDI-TOF) m/z 672 [M]þ (100%); HRMS (ESI)
(C41H25MgN7O2) [MþH]þ: calcd: 671.1915; found: 671.1923
[MþH]þ.
4 . 5 . 3 . ( 2 0 - ( 1 - P y r e n y l ) - t e t r a b e n z o [ b , g , q , l ] - 5 ,10 ,15 -
triazaporphyrinato)magnesium 24. Synthesised following the gen-
eral procedure described above using a solution of phthalonitrile
(154.0 mg, 1.20 mmol) and MgBr2 (110.0 mg, 0.60 mmol) in dry
diglyme (1.0 ml), heating at 220 ꢀC ꢀC for 10 min under argon and
initially adding aminoisoindoline 23 (138 mg, 0.40 mmol) and
phthalonitrile (51.0 mg, 0.40 mmol) in dry diglyme (1.5 ml) over
30 min. Finally, a solution of phthalonitrile (51.0 mg, 0.40 mmol)
and DABCO (6 mg, 0.60 mmol) in dry diglyme (0.5 ml) was added
dropwise over 30 min and the mixture heated for a further 1.5 h.
The crude product was purified by column chromatography using
AcOEt/PE (1:3) then AcOEt/PE/THF (3:10:1) as eluent gradient.
Recrystallisation from THF and hexane gave 24 as green-purple
crystals (35 mg, 12%); mp >300 ꢀC; UVevis (THF) lmax/nm (
) 670
3
(7.35ꢁ103), 647 (4.41ꢁ103), 592 (1.03ꢁ102), 442 (1.03ꢁ102), 397
(2.50ꢁ102); nmax/cmꢂ1 (ATR) 3054, 1606, 1512, 1481, 1328; 1H NMR
(500 MHz, THF-d8, 298 K):
d (ppm) 9.55e9.50 (m, 6H), 8.79 (d,
4.5.1. (20-(3-Methoxyphenyl)-tetrabenzo[b,g,q,l]-5,10,15-
triazaporphyrinato)magnesium 20. Synthesised following the gen-
eral procedure described above using a solution of phthalonitrile
(154.0 mg, 1.20 mmol) and MgBr2 (110.0 mg, 0.60 mmol) in dry
J¼7.6 Hz, 1H), 8.75 (d, J¼7.6 Hz, 1H), 8.59 (d, J¼9.2 Hz, 1H), 8.46 (d,
J¼9.2 Hz, 1H), 8.42 (dd, J¼7.3, 1.6 Hz, 1H), 8.20e8.17 (m, 4H), 8.09
(dd, J¼7.3, 1.6 Hz, 1H), 8.06 (t, J¼7.3 Hz, 1H), 7.71 (ddd, J¼7.5, 7.0,
0.7 Hz, 2H), 7.61 (d, J¼9.4 Hz, 1H), 7.50 (d, J¼9.4 Hz, 1H), 7.09 (ddd,